Pharmacy Practice & Science Department Highlights: July 2024

Aug. 5, 2024
A pharmacist speaking with a patient during a health fair.

 

Publications

Ivo Abraham
Abraham I, Crawford J, Schwartzberg L. On-body injector pegfilgrastim for chemotherapy-induced neutropenia prophylaxis: current status. Cancer Treatment and Research Communications 2024;40:100824.

Lewandrowski K-U, Lyra da Silva RC, Elfar JC, Alhammoud A, Mogamis IS, Burkhardt BW, Oertel JM, Landgraeber S, Fiorelli RKA, De Carvalho PST, Abraham I, León JFR, Martinez E, Lorio MP. Disability-adjusted life years from bone and joint infections associated with antimicrobial resistance: an insight from the 2019 Global Burden of Disease study. International Orthopaedics 2024;48:1677-1688.

Gamaleldin M, Abraham I, Meabed MH, Elberry AA, Abdelhaim SM, Hussein AFM, Waggas DS, Hussein RRS. Manuka combinations with Nigella Sativa and hydroxyurea in treating iron overload in pediatric ß-thalassemia major: randomized clinical trial. Heliyon 2024;10:e33707.

Okechukwu A, Magrath P, Alaofe H, Farland L, Abraham I, Marrero DG, Celaya M, Ehiri J. Optimizing postpartum care for disparity populations – perspectives and priorities of rural, minority, low-income childbearing women. Maternal and Child Health Journal 2024;28:1148-1159.

MacDonald K, Pondel, Abraham I. Cost-efficiency and budget-neutral expanded access modeling of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal cancer. Journal of Medical Economics 2024;27(Suppl.3):1-8.

Gamaleldin M, Abdelhalim S, Abraham I. Application of artificial intelligence models in pharmacovigilance. In Badria FA (ed), Pharmacovigilance – facts, challenges, limitations, and opportunities. London, UK: InTechOpen, 2024.